In the modern clinical environment, the demand for precision, safety, and patient mobility has propelled the Disposable Infusion Pump market into a new era. As a leading China Wholesale Disposable Infusion Pumps Exporter, we recognize that these devices are no longer just plastic consumables; they are critical components in post-operative pain management, oncology, and chronic disease therapy.
The global elastomeric pump market is projected to reach USD 1.2 billion by 2028. This growth is driven by the shift toward ambulatory care and the increasing prevalence of cancer requiring continuous chemotherapy.
Modern infusion pumps now integrate advanced anti-free-flow valves, precision flow-rate regulators, and air-eliminating filters to ensure the highest reliability during autonomous drug delivery.
From high-volume hospitals in Europe to mobile clinics in Southeast Asia, our pumps are designed with universal Luer locks and localized labeling to meet diverse regulatory environments.
The evolution of disposable infusion technology has shifted from heavy electronic pumps to lightweight, disposable elastomeric systems. This transition offers several Information Gain advantages:
Our facility in Jiangsu province utilizes automated assembly lines that reduce human error and ensure every pump undergoes rigorous pressure and flow-rate testing.
Strategically located near the Shanghai Port, we offer unparalleled shipping speeds, ensuring that wholesale orders reach global markets in record time.
Our R&D team continuously improves the elastomeric bladder’s consistency, solving the industry challenge of flow-rate "tail-off" at the end of the infusion cycle.
1. Post-Operative Analgesia: Patients undergoing orthopedic or abdominal surgeries benefit from Continuous Basal Infusion (CBI) which provides a steady stream of pain relief, reducing the need for opioids.
2. Oncology & Chemotherapy: Fluorouracil (5-FU) protocols often require 48-hour continuous infusion. Our pumps provide the precision required for these cytotoxic drugs.
3. Labor & Delivery: Epidural analgesia using disposable pumps allows for Patient-Controlled Analgesia (PCA) buttons, empowering expectant mothers during the delivery process.
Shanghai Ryu Medical Co., Ltd. is one of the professional suppliers for the Medical Instrument products in China. Our Team has more than 10 years experiences in Medical field. We export our products to customers in Europe, Africa, Asia and America. We are factory, located in Jiangsu province, which near Shanghai port, we produce syringe, infusion set, Gloves and Face mask.
In order to fulfill and increasing needs of our trusted and loyal customers, apart from our factory, we have more than 5 strategic partners which produce urine bags, surgical gowns, Medical Tubes, Wound Dressing syringes diagnostics & lab products.
We care the success of our customers, we know that the important of quality, so we set up a strong QC team stay in differences production lines to ensure & control quality. Our Company is approved by CE&ISO certificates for most of products.
In future, Ryu Medical will keep high efficient and professional for every customer, and associating company development with human health. We will keep putting love and respect into our every product all the way, and do our best effort to bring health to everyone at the world.
A: Our pumps maintain a ±10% accuracy rate under standard temperature and pressure conditions, meeting the stringent requirements of ISO 28620:2010 standards for non-electrically driven portable infusion devices.
A: The PCA module features a lockout time mechanism (e.g., 6, 12, or 15 minutes) to prevent overdose while allowing the patient to self-administer a bolus dose for breakthrough pain.
A: Yes, our pumps are constructed with DEHP-free medical grade PVC and amber-tinted options to protect light-sensitive medications common in oncology protocols.
A: Absolutely. As a leading exporter, we provide full OEM/ODM services including multi-language packaging and specific flow rate calibrations tailored to local clinical preferences.
A: Through our "Factory 4.0" initiative, we integrate real-time QC monitoring. Every batch is subjected to destructive testing and 100% leak testing before sterilization by Ethylene Oxide (EO).